operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-08Mar2022 Final

Page 137

Incidents 44.1 Incident management The site team should be trained and prepared to respond to three possible medical emergencies associated with COVID-19 vaccination: fainting, hyperventilation, and anaphylaxis. The appropriate medication and equipment must be on site to manage these incidents. Refer to section 2.3 of the Immunisation Handbook for guidance on emergency equipment required to manage post-vaccination medical emergencies. Adverse events should be managed in accordance with HQSC Guide to the National Adverse Events Reporting Policy 2017. In the event of a serious adverse event or incident it is important to follow organisational process to report, review, and learn from the incident. •

Appendix I outlines the process steps for notifying serious incidents to the programme. This includes the COVID-19 Vaccine related severity assessment codes (SAC) and the form required to notify the programme of incident and serious adverse events.

44.2 Adverse events during observation period If any consumer has an adverse event during the 15-minute observation period at the vaccination site, appropriate medical attention must be provided. The on-site adverse event must be recorded and submitted in the CIR to support reporting on adverse events following COVID-19 vaccine immunisation. For more information regarding managing medical emergencies and anaphylaxis, please see section 2.3 of the Immunisation Handbook.

44.3 Recording an anaphylaxis event Where a suspected anaphylaxis event occurs following a vaccination event, it is important to record and submit consumer details of the event in the CIR. The person who handled the event must complete the anaphylaxis checklist record (found on the IMAC website) as soon as practical. The anaphylaxis checklist should be completed and uploaded via the Dropbox to the CARM link. Adverse events should be notified to the site lead clinician, who can undertake a clinical review and determine appropriate actions with the site manager (such as pausing vaccinations for a time, should this be required).

Version 34.0 Page 137


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 168-169

Appendix G: Vaccination site screening questions

2min
page 159

Appendix J: Risk mitigations for vaccination sites

2min
page 167

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 156-157

Appendix D: Logistics and inventory management

1min
page 155

Incidents

6min
pages 137-141

Variations

1min
page 142

Affected persons under the Vaccinations Order

4min
pages 128-130

National Immunisation Booking System

11min
pages 131-136

Home vaccinations

2min
pages 125-126

Mobile vaccination team

1min
page 124

COVID-19 Trial Vaccinations

1min
page 127

Vaccination in Hospital

1min
page 123

Vaccination and Surveillance Testing

1min
page 122

Third primary dose for severely immunocompromised

1min
page 121

Section F: Additional programme guidance, variations and incidents

1min
page 117

Vaccination in high-risk or screened ‘positive’ consumers

5min
pages 118-120

Novavax Operational phase

1min
page 108

Novavax Vaccine administration and observation

8min
pages 111-116

Novavax Preparation of doses

2min
pages 109-110

Booking and scheduling

1min
page 107

Section E: Novavax (Nuvaxovid) COVID-19 Vaccine

1min
page 106

AstraZeneca Vaccine administration and observation

8min
pages 100-105

AstraZeneca Preparation of doses

2min
pages 98-99

AstraZeneca Operational phase

1min
page 97

Paediatric Pfizer Vaccine administration and observation

9min
pages 89-94

Section D: AstraZeneca COVID-19 Vaccine

1min
page 95

Booking and scheduling

1min
page 96

Paediatric Pfizer Preparation of doses

3min
pages 86-88

Vaccine safety and additional considerations for consumers aged 5 to 11 years

1min
page 85

Pfizer Vaccine administration and observation

13min
pages 72-81

Booking and scheduling

3min
pages 62-64

Vaccinating consumers aged 12 to 15 years

1min
page 68

Pfizer Preparation of doses

4min
pages 69-71

Pfizer Operational phase

2min
pages 66-67

Protecting security and privacy

1min
page 65

Becoming a COVID-19 Vaccination site

1min
page 60

Site readiness and closure

1min
page 59

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 57-58

COVID-19 Immunisation Register

3min
pages 29-31

Preparing the vaccination workforce

7min
pages 22-26

Infection prevention and control (IPC

2min
pages 27-28

Section A: Ready to vaccinate

1min
page 15

Site considerations

7min
pages 18-21

Equipment ordering and demand planning

7min
pages 33-38

Vaccine storage and handling

8min
pages 39-44

Logistics

1min
page 32
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.